Answers are grounded in this paper and cite their sources.
Observational analysis reveals elevated risks of lung metastasis and death after SARS-CoV-2 in cancer survivors, highlighting respiratory infections as triggers for cancer relapse.
T cell activation and cytotoxicity. Crucially, these experimental findings align with human observational data. Analyses of cancer survivors from the UK Biobank (all cancers) and Flatiron Health (breast cancer) databases reveal that SARS-CoV-2 infection substantially increases the risk of cancer-related mortality and lung metastasis compared with uninfected cancer survivors. These discoveries underscore the huge impact of respiratory viral infections on metastatic cancer resurgence, offering new insights into the connection between infectious diseases and cancer metastasis.
No takes yet. Share an insight, caveat, or question.
Chia et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: